| Financial Year |
March 31 2023 |
| Monetary Funds |
224,238,506.08 |
| Held-for-trading Financial Assets |
60,000,000.00 |
| Notes Receivable |
12,267,574.80 |
| Accounts Receivable |
270,951,345.39 |
| Advances to Suppliers |
8,580,854.90 |
| Other Receivables |
9,569,212.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,464,336.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,677,170.03 |
| Total Current Assets |
591,913,622.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
23,367,535.47 |
| Investment Properties |
805,192.65 |
| Fixed Assetes |
5,382,324.14 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,084,057.78 |
| R&D expenses |
-- |
| Goodwill |
76,868,897.50 |
| Long-Term Deferred and Prepaid Expenses |
1,739,539.37 |
| Deferred Income Tax Assets |
13,665,398.01 |
| Other Non-Current Assets |
28,075,831.15 |
| Sub-Total of Non-Current Assets |
199,054,770.90 |
| Total Assets |
790,968,393.53 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
18,644,277.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,964,293.74 |
| Taxes Payable |
24,188,904.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,286,469.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,565,039.58 |
| Other Current Liabilities |
10,967,574.80 |
| Sub-Total of Current Liabilities |
99,481,547.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,918,676.65 |
| Total Liabilities |
131,400,224.00 |
| Paid-In Capital(Or Share Stock) |
63,585,000.00 |
| Capital Surplus |
526,494,568.65 |
| Surplus Reserve |
21,844,214.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
12,890,285.97 |
| Minority Stockholder's Interest |
34,754,100.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
624,814,069.49 |
| Owner's Equity（Stockholder's Equity） |
659,568,169.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
790,968,393.53 |
